Aakar Medical Technologies IPO GMP & Review: Apply or Avoid?

Aakar Medical Technologies IPO is open for bidding on 20th June 2025. It is a bookbuilding IPO that comprises a fresh issue of 37.50 lakh shares worth ₹27.00 crores. The issue will be listed on NSE and SME on its tentative listing date, 27th June 2025. 

Aakar Medical Technologies IPO Details 

Aakar Medical Technologies IPO date is fixed between 20th June 2025 and 24th June 2025. The face value of Aakar Medical Technologies Limited shares stands at ₹10 per share, and the IPO price band is fixed at ₹68 to ₹72 per share. 

Bigshare Services Private Limited is the registrar of the Aakar Medical Technologies IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Aakar Medical Technologies IPO Share Reservation

Aakar Medical Technologies IPO is a bookbuilding IPO issue of 37.50 lakh shares worth ₹27.00 crores. Aakar Medical Technologies Limited shares will be listed on the NSE and SME. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Aakar Medical Technologies IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on Aakar Medical Technologies IPO GMP? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 19th June 2025, Aakar Medical Technologies IPO GMP stands at ₹0 per share, which means the share will likely show a listing at ₹72 (72+0) on its tentative listing date, 27th June 2025.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Aakar Medical Technologies IPO. Stay informed with Univest to know about real-time insights on IPOs and their GMP trends. 

Aakar Medical Technologies IPO Review

Check out the detailed Aakar Medical Technologies IPO review for a thorough understanding of its potential to report listing gains on 27th June 2025. The Aakar Medical Technologies IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the growth margins and declines of the business financials before applying for the Aakar Medical Technologies IPO.

Aakar Medical Technologies Limited’s revenue rose 33.47% from ₹46.27 crores in March 2024 to ₹61.76 crores in March 2025. Moreover, the company’s PAT increased by 110.45% from ₹2.87 crores to ₹6.04 crores.  

Aakar Medical Technologies Limited has shown consistent revenue growth, indicating that the company is financially stable. Moreover, the brokers, investors, and RAs have a positive outlook for the Aakar Medical Technologies IPO for its tentative listing day, which is 27th June 2025.  

Technical Analysis

A number of technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the Aakar Medical Technologies IPO.

The PE ratio of Aakar Medical Technologies Limited shares is 12.43, and its Earnings Per Share (EPS) stands at 5.79. The Aakar Medical Technologies IPO can potentially deliver gains on its tentative listing date, 27th June 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Aakar Medical Technologies Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Aakar Medical Technologies IPO Subscription Status

Aakar Medical Technologies IPO is now open for bidding on 20th June 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Aakar Medical Technologies IPO Subscription Status. 

About Aakar Medical Technologies Limited

Aakar Medical Technologies Limited was incorporated in 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialised cosmetic products and devices.

The company deals in speciality products for Dermatologists, Plastic Surgeons, Aesthetic Physicians, Cosmetologists. The company’s product portfolio encompasses both own brands, which consist of domestically manufactured products and internationally produced devices, and imported brands sourced from countries such as South Korea, Spain, Italy, and Austria.

Aakar Medical Technologies Limited Financials

The company’s financial analysis is essential before applying for the Aakar Medical Technologies IPO. Look at the table to learn about Aakar Medical Technologies Limited’s financials. 

Explanation

Aakar Medical Technologies Limited’s revenue rose 33.47% from ₹46.27 crores in March 2024 to ₹61.76 crores in March 2025. Moreover, the company’s PAT increased by 110.45% from ₹2.87 crores to ₹6.04 crores. 

Aakar Medical Technologies IPO Bidding Requirements

Aakar Medical Technologies IPO has reserved lot sizes to be applied by different investor categories. Look at the table below to know about the requirements to be fulfilled for applying for this IPO. 

Use the lot size calculator to find how many shares you should apply!

Aakar Medical Technologies IPO Promoter Holdings

Have a look at the table below to check the holdings of Aakar Medical Technologies Limited’s promoters: Dilip Ramesh Meswani and Bindi Dilip Meswani. 

Note: Promoter Holdings’ value is to be calculated using Equity dilution, which represents the gap between shareholdings before and after the Issue. 

Aim of Aakar Medical Technologies IPO

The primary aim of Aakar Medical Technologies IPO is to raise ₹27.00 crores. On the other hand, Aakar Medical Technologies Limited has decided to utilise these funds in different practices. Explore some of the secondary objectives for Aakar Medical Technologies IPO.

• To meet general corporate purposes. 
• To meet working capital requirements. 

Should I Invest in the Aakar Medical Technologies IPO?

“AMTL is dealing in a wide range of aesthetics products and related devices. It posted growth in its top and bottom lines for the reported periods. The sudden boost in top and bottom lines in a pre-IPO year i.e., FY25 raise eyebrows and concern over its sustainability going forward. Based on its recent financial data, the issue appears aggressively priced. Well-informed/cash surplus investors may park moderate funds for long term. ”~Dilip Davda (Chief Editor at Chittorgarh)

Explore the pros and cons of Aakar Medical Technologies IPO to know whether you should apply or avoid the issue. These pros and cons might help you know about the IPO’s efficiency in delivering profits in the coming decades. 

Pros of Aakar Medical Technologies IPO

• Experienced and Qualified Promoters
• Diverse and Innovative Product Portfolio

Cons of Aakar Medical Technologies IPO

• Low Employee Base
• Low Market Capitalisation

How to Apply for Aakar Medical Technologies IPO?

Check the steps mentioned below to apply for the Aakar Medical Technologies IPO. 

• Step 1: Conduct thorough research on Aakar Medical Technologies IPO GMP, subscription status, issue size, lot size, and other details. 
• Step 2: Open a demat account on Univest to learn about real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for one lot of 1,600 shares worth ₹1,15,200 of Aakar Medical Technologies IPO.   
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Aakar Medical Technologies IPO from more than one demat account to increase your allotment chances. 

How to Check Aakar Medical Technologies IPO Allotment Status?

You can check for Aakar Medical Technologies IPO allotment in different ways. These include NSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On NSE

• Visit the NSE Official Website.
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose Aakar Medical Technologies IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal. 
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Aakar Medical Technologies IPO allotment status.

Let’s Wrap

Aakar Medical Technologies IPO is a bookbuilding issue of 37.50 lakh shares worth ₹27.00 crores. The shares of Aakar Medical Technologies Limited will be listed on NSE and SME on its tentative listing date of 27th June 2025. Researching Aakar Medical Technologies IPO GMP and reviews is highly suggested to book your ideal profitability. Brokers and investors have highlighted its pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on Aakar Medical Technologies IPO

How is the Aakar Medical Technologies IPO?

Ans. Currently, on 19th June 2025, Aakar Medical Technologies IPO GMP (Grey Market Premium) stands at ₹0 (0.00% up). It indicates that the estimated listing price could be ₹72 per share.  It is a bookbuilding IPO that comprises a fresh issue of 37.50 lakh shares worth ₹27.00 crores. The face value of each share of Aakar Medical Technologies Limited is ₹10. 

What is the Aakar Medical Technologies IPO price?

Ans. Aakar Medical Technologies IPO price band has been set between ₹68 and ₹72 per share. Retail investors can apply for a minimum of 1 lot consisting of 1,600 shares worth ₹1,15,200. Moreover, HNIs are required to bid for a minimum of 2 lots (3,200 shares) worth ₹2,30,400. 

Is the Aakar Medical Technologies IPO good?

Ans. During FY24- 25, Aakar Medical Technologies Limited’s revenue rose 33.47% from ₹46.27 crores in March 2024 to ₹61.76 crores in March 2025. Moreover, the company’s PAT increased by 110.45% from ₹2.87 crores to ₹6.04 crores. Investors can analyse other relevant factors and make a decision accordingly.

Who is the registrar of the Aakar Medical Technologies IPO?

Ans. Bigshare Services Private Limited is the registrar of Aakar Medical Technologies IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding Aakar Medical Technologies IPO allotment and refund, you can contact Maashitla Securities Private Limited at investor@bigshareonline.com or +91-22-6263 8200.

What is the issue size of the Aakar Medical Technologies IPO? 

Ans. Aakar Medical Technologies IPO is a bookbuilding IPO for 37.50 lakh shares worth ₹27.00 crore. Moreover, the IPO is set to open on 20th June 2025 and will be closed on 24th June 2025. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Aakar Medical Technologies IPO, download the Aakar Medical Technologies IPO RHP and Aakar Medical Technologies IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Current & Previous IPOs

Read Our Articles on the Best Stocks

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest in India

What is Earnings Per Share EPS? 

Top Multibagger Penny Stocks For 2025 |  Potential Picks

Also Explore

Univest Screeners

Explore Webstories on Univest 

1. Best Time To Buy Dividend Stocks

2. How RBI Policies Affect Dividend Stocks

3. Can Dividend Stocks Beat Inflation

4. What Is The Dividend Aristocrat List

5. Which Indian Psus Offer The Best Dividends

6. Large Cap Vs Small Cap Dividend Stocks